The effect of fenofibrate on early retinal nerve fiber layer loss in type 2 diabetic patients: a case-control study

Table 2 The peripapillary RNFL thickness of fibrate user and non-fibrate user

Eyes	Non-fibrate users (n = 41)	Fibrate users (n = 48)	t	p
Right eye
Superior quadrant	111.8 ± 3.596	123.0 ± 3.083	−2.384	*0.019
Inferior quadrant	120.4 ± 3.148	130.0 ± 3.925	−1.863	0.066
Nasal quadrant	70.95 ± 3.065	69.94 ± 2.252	0.271	0.787
Temporal quadrant	78.12 ± 3.021	76.02 ± 1.844	0.605	0.547
Average	95.89 ± 2.611	99.08 ± 2.192	0.940	0.351
Left eye
Superior quadrant	116.7 ± 3.701	125.5 ± 3.262	−1.788	0.077
Inferior quadrant	124.7 ± 3.397	132.4 ± 3.985	−1.072	0.286
Nasal quadrant	72.51 ± 2.547	69.10 ± 2.127	1.035	0.303
Temporal quadrant	73.32 ± 1.59	72.38 ± 1.504	0.429	0.668
Average	96.95 ± 2.386	99.90 ± 2.089	−0.932	0.353

RNFL retinal nerve fiber layer. Data was presented as means ± SD of each group. *P < 0.05. P < 0.05 was considered statistically significant between the fibrate user and non-fibrate user group

ISSN: 1471-2415